University of Ioannina
Διερεύνηση του ρόλου των αδρενεργικών και ντοπαμινεργικών συστημάτων στη ρύθμιση των κυτοχρωμάτων CYP3A1/2, CYP2C11 και CYP2D1/2
Abstract
dc:descriptionThe hepatic cytochrome CYPs (P450s) consitute a large superfamily of proteins that are expressed in all living organisms. Their role is crucial, since they metabolize a broad variety of substrates, both endogenous and exogenous (xenobiotics). From pharmacological point of view, the most important subfamilies of CYPs are the CYP3A, CYP2C and CYP2D, because they are involved in the metabolism of the majority of the most commonly prescribed drugs. The knowledge regarding factors that might affect their regulation is of paramount significance, because it is well established that any factor modifying the expression and activity of CYPs may lead to complications in drug therapy. In particular, induced CYP expression may lead to increased hepatic drug metabolism and consequently, to reduced drug concentrations in plasma, followed by reduced drug efficacy or even sometimes the complete failure of the pharmacotherapy. On the other hand, inhibition of CYPs may lead to reduced hepatic drug metabolism and thus, to elevated concentrations of the drug in plasma, a condition usually connected to the development of detrimental side-effects. This study aimed to serve several purposes. The first purpose of this study was to evaluate the impact of stress and glucocorticoids on the regulation of the most important hepatic CYPs (CYP3A, CYP2C and CYP2D) in the rat. Within the scopes of the present study was the investigation of the role of alpha- and beta- adrenergic receptor-linked pathways and the impact of the related signaling pathways (cAMP/PKA, JNK, GH/STAT5b) in the regulation of the aforementioned CYPs. The role of D2-dopaminergic receptors and the related signaling pathways, PI3K/Akt/FoxO1and GH/STAT5b, in the regulation of the main hepatic CYPs was also investigated. In vivo and in vitro experiments were employed to address these subjects, using adult male Wistar rats and primary hepatocyte cultures, respectively. Alterations in CYP-dependent enzymatic activities were assessed using the High Performance Liquid Chromatography (HPLC). Modifications of the specific CYP expressions were also evaluated at apoprotein and mRNA level, employing either western blot or q-PCR analysis, respectively. For this purpose, specific antibodies and primers were used. The results of this study have clearly indicated psychological stress as an extremely important factor in the regulation of the most important CYPs. In particular, rats that responded to early in life maternal deprivation stress, showed induced hepatic expression of CYP3A1/2 and CYP2C11, while the CYP2D was not significantly affected. In contrast, repeated exposure to restraint stress resulted in significant changes in the hepatic expression of CYP3A2 and CYP2D. The effect of both types of stress on CYP2A was less pronounced. Moreover, the inductive effect of glucocorticoids on CYP3A and their inhibitory effect on CYP2C was confirmed. The in vitro and in vivo experiments that have focused on the role of adrenergic receptor pathways, revealed that the signaling pathways cAMP/PKA, JNK and GH/STAT5b hold major roles in the regulation of the above mentioned CYPs. In this regulation, several nuclear receptors have a determinant role. In vivo experiments using the D2-dopaminergic receptor blocking agent, sulpiride, indicated a dramatic inhibition of the hepatic CYP3A, CYP2C and CYP2D expression. Nonetheless, in vitro experiments indicated that the direct blockade of hepatic D2-receptors by sulpiride had opposite effects. Based on these findings, we hypothesized that insulin may be involved in the in vivo sulpiride-induced downregulating effect on hepatic CYPs. Further investigation of this hypothesis using primary hepatocytes treated with insulin alone or in combination with wortmannin, an inhibitor of the insulin-regulated PI3K/Akt signaling pathway, combined to the in vivo sulpiride effects on this signaling pathway, has strengthened the basis of this hypothesis. Further studies showed that the transcription factor FoxO1, holds a significant role in the regulation of the aforementioned CYPs. Moreover, the data of this study revealed the participation of the GH/STAT5b signaling pathway in the stress-, AR- and D2-receptor-mediated modifications in CYP regulation. In conclusion, this study indicated that stress and the major components of the stress system, glucocorticoids and adrenergic receptors, hold determinant roles in the regulation of the hepatic drug metabolizing enzymes. This fact should always be taken into account before initiating a pharmacotherapy. Furthermore, this study has shown for the first time that, profoundly, the pancreatic D2-dopaminergic receptors and the PI3K/Akt/FoxO1 signaling pathway hold a key role in the regulation of CYP3A, CYP2C and CYP2D in the rat liver. Finally, this study has shed light in the involvement of various hormones in the stress-, AR- and D2-receptor mediated regulation of the aforementioned cytochromes and has enriched our knowledge regarding the role of the nuclear transcription factors CAR, PXR, RXR and HNFs in this regulation.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2012
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Daskalopoulos, Evangelos-Panagiotis
- Δασκαλόπουλος, Ευάγγελος-Παναγιώτης
Subjects
dc:subject × 16Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/35350